NYSE Euronext
(NYX) today announced trading volumes for its global cash equities and
derivatives exchanges for
Highlights
NYSE , NYSE Arca and NYSE Amex (“NYSE Group”) U.S. cash products handled average daily volume (“ADV”) inMay 2009 increased 40.4%, compared toMay 2008 and included strong growth inNYSE -listed (Tape A) and NYSE Arca/Amex-listed (Tape B) trading volumes.NYSE Group matched share of all U.S. equity trading volume inMay 2009 was 30.1%, compared to market share of 20.7% for our next largest competitor.NYSE Euronext is the largest exchange operator in the two fastest growing tapes in the U.S. equity markets. Total Tape A consolidated ADV and Tape B consolidated ADV inMay 2009 increased a combined 86.5%, compared toMay 2008 . Tape A and Tape B trading volume in May accounted for approximately 80% of all Consolidated Tape trading in the U.S. market which includes trade reporting facility (“TRF”) volumes.- NYSE Euronext European cash products ADV of
1.5 million transactions in
May 2009 increased 14.6%, compared toMay 2008 , but decreased 6.8% fromApril 2009 . European cash ADV year-to-date of 1.4 million transactions was only 6.0% below the same period last year. - NYSE Euronext European derivatives products
ADV in
May 2009 was a record 5.6 million contracts, up 28.4% fromMay 2008 and up 24.6% fromApril 2009 levels, driven by record Bclear OTC volumes. Total interest rate products ADV was 2.2 million contracts, up 8.2% compared toMay 2008 and at their highest levels sinceOctober 2008 . - NYSE Euronext U.S. equity options ADV of
2.5 million contracts in
May 2009 represented an increase of 73.4%, compared toMay 2008 levels. The increase in ADV was driven mostly by the addition of the former Amex options business and stronger options market volumes.
Cash Trading
U.S. Cash
NYSE Group U.S. cash products handled ADV in
- Total Tape A consolidated ADV in
May 2009 increased 66.9% to 6.5 billion shares compared to 3.9 billion shares inMay 2008 , but declined 0.7% compared toApril 2009 . Year-to-date, total Tape A consolidated ADV of 6.4 billion shares was 49.7% above the prior year period. - Tape A matched ADV of
NYSE Group increased 39.7% to 2.5 billion shares, compared to 1.8 billion shares inMay 2008 , but declined 1.6% compared toApril 2009 . Year-to-date,NYSE Group matched ADV in Tape A increased 20.4% compared to the prior year period. - NYSE Group’s Tape A matched market share
in May was 38.9%, compared to market share of 15.7% for our next largest
competitor. TRF market share across Tape A increased in
May 2009 to 33.2% from 25.0% inDecember 2008 . - Designated Market Maker (“DMM”)
participation in May was 10.1%, compared to 9.8% in April. Supplemental
Liquidity Provider (“SLP”) participation in May was 6.8%, down from 7.3%
in April. Please note that the calculation for SLP participation has changed
to reflect the roll-out of the SLP program to a broader universe of
NYSE stocks, from the original 500 eligible stocks. DMM and SLP participation pertain only to trading onNYSE .
NYSE Arca and NYSE Amex-listed (Tape B)
- Total Tape B consolidated ADV in
May 2009 increased 173.0% to 2.4 billion shares compared to 882 million shares inMay 2008 , and increased 1.6% compared toApril 2009 . Year-to-date, total Tape B consolidated ADV of 2.4 billion shares was 125.6% above the prior year period. - NYSE Group’s matched ADV of Tape B in
May 2009 increased 127.3% to 552 million shares compared toMay 2008 , but declined 2.5% compared toApril 2009 . Year-to-date, NYSE Group Tape B matched ADV was 88.0% above the prior year period. - Tape B matched market share of
NYSE Group was 22.9%, compared to market share of 22.3% for our next largest competitor. TRF market share across Tape B increased inMay 2009 to 36.9% from 21.5% inDecember 2008 .
Nasdaq-listed (Tape C)
- Total Tape C consolidated ADV in
May 2009 increased 17.0% to 2.4 billion shares, compared to 2.1 billion shares inMay 2008 . Tape C consolidated volumes represented only 21.4% of all Consolidated Tape trading in the U.S. inMay 2009 . Year-to-date, total Tape C consolidated ADV was 0.9% above the prior year period. - NYSE Group’s matched ADV of Tape C
decreased 6.5% to 337 million shares in
May 2009 compared to 360 million shares inMay 2008 . Year-to-date, NYSE Group’s Tape C matched ADV decreased 9.6% to 343 million shares. - NYSE Group’s Tape C matched market share
was 13.9%, compared to 32.7% for our nearest competitor. TRF market share
across Tape C increased in
May 2009 to 38.1% from 29.9% inDecember 2008 .
Exchange Traded Funds
NYSE Group matched exchange-traded funds ADV (included in volumes from Tape B and Tape C noted above) increased 113.0% to 548 million shares inMay 2009 .
European Cash
Derivatives Trading
European Derivatives
NYSE Euronext European derivatives products ADV in
- Total interest rate products ADV increased
8.2% to 2.2 million contracts from 2.0 million contracts in
May 2008 and increased 15.5% fromApril 2009 . Total interest rate products ADV is at its highest level sinceOctober 2008 . Year-to-date, total interest rate products ADV decreased 21.6% compared to the prior year period. - Total equity products (including Bclear)
ADV increased 46.4% to 3.4 million contracts from
May 2008 and increased 32.2% compared toApril 2009 . Total equity products ADV in May executed through our full-service CONNECT trading platform was 1.0 million contracts, in line withMay 2008 andApril 2009 . Year-to-date total equity products ADV increased 18.1% above the prior year period. - The increase in total equity products ADV
was driven in large part by a 54.4% increase in individual equity products
compared to
May 2008 and a 44.9% increase compared toApril 2009 . The increase in individual equity products ADV was driven by an increase in single-stock futures trading through Bclear.
U.S. Derivatives
NYSE Euronext’s U.S. equity options (NYSE Arca and NYSE Amex) ADV in
Please click here for the Monthly Transaction Activity Data Table.
1 Euronext equities transactions count each buy and sell
order as separate transactions,
NYSE Euronext | ||||||||||||||||||||
Monthly Volume Summary - Cash Products |
||||||||||||||||||||
Average Daily Volume | Total Volume | Average Daily Volume | Total Volume | |||||||||||||||||
(Unaudited) | May-09 | May-08 | % Chg | May-09 | May-08 | % Chg | YTD 2009 |
% Chg vs. YTD 2008 |
YTD 2009 |
% Chg vs. YTD 2008 |
||||||||||
Number of Trading Days - European Markets | 20 | 21 | 20 | 21 | 103 | 103 | ||||||||||||||
Number of Trading Days - U.S. Markets | 20 | 21 | 20 | 21 | 102 | 102 | ||||||||||||||
European Cash Products (trades in thousands) | 1,475 | 1,287 | 14.6% | 29,491 | 27,029 | 9.1% | 1,435 | -6.0% | 147,778 | -7.8% | ||||||||||
Equities | 1,418 | 1,243 | 14.1% | 28,356 | 26,096 | 8.7% | 1,370 | -6.9% | 141,148 | -8.6% | ||||||||||
Exchange-Traded Funds | 15 | 6 | 157.7% | 306 | 125 | 145.4% | 14 | 83.3% | 1,487 | 79.8% | ||||||||||
Structured Products | 36 | 34 | 7.9% | 724 | 704 | 2.8% | 44 | 8.1% | 4,577 | 6.0% | ||||||||||
Bonds | 5 | 5 | 5.7% | 106 | 105 | 0.7% | 6 | -1.5% | 567 | -3.4% | ||||||||||
U.S. Cash Products (shares in millions) 2 | 3,832 | 2,730 | 40.4% | 76,648 | 57,328 | 33.7% | 3,962 | 23.4% | 404,149 | 21.1% | ||||||||||
NYSE Listed (Tape A) Issues 1 | ||||||||||||||||||||
NYSE Group Handled Volume 2 | 2,787 | 2,016 | 38.2% | 55,731 | 42,329 | 31.7% | 2,880 | 20.3% | 293,734 | 18.0% | ||||||||||
NYSE Group Matched Volume 3 | 2,526 | 1,808 | 39.7% | 50,514 | 37,965 | 33.1% | 2,606 | 20.4% | 265,820 | 18.1% | ||||||||||
Total NYSE Listed Consolidated Volume | 6,490 | 3,889 | 66.9% | 129,791 | 81,673 | 58.9% | 6,431 | 49.7% | 655,985 | 46.8% | ||||||||||
NYSE Group Share of Total Consolidated Volume | ||||||||||||||||||||
Handled Volume 2 | 42.9% | 51.8% | -8.9% | 42.9% | 51.8% | -8.9% | 44.8% | -10.9% | 44.8% | -10.9% | ||||||||||
Matched Volume 3 | 38.9% | 46.5% | -7.6% | 38.9% | 46.5% | -7.6% | 40.5% | -9.9% | 40.5% | -9.9% | ||||||||||
NYSE Arca & Amex (Tape B) Listed Issues | ||||||||||||||||||||
NYSE Group Handled Volume 2 | 634 | 283 | 123.7% | 12,678 | 5,950 | 113.1% | 668 | 85.1% | 68,100 | 81.5% | ||||||||||
NYSE Group Matched Volume 3 | 552 | 243 | 127.3% | 11,046 | 5,102 | 116.5% | 585 | 88.0% | 59,714 | 84.4% | ||||||||||
Total NYSE Arca & Amex Listed Consolidated Volume | 2,407 | 882 | 173.0% | 48,143 | 18,516 | 160.0% | 2,373 | 125.6% | 242,073 | 121.3% | ||||||||||
NYSE Group Share of Total Consolidated Volume | ||||||||||||||||||||
Handled Volume 2 | 26.3% | 32.1% | -5.8% | 26.3% | 32.1% | -5.8% | 28.1% | -6.2% | 28.1% | -6.2% | ||||||||||
Matched Volume 3 | 22.9% | 27.6% | -4.7% | 22.9% | 27.6% | -4.7% | 24.7% | -4.9% | 24.7% | -4.9% | ||||||||||
Nasdaq Listed (Tape C) Issues | ||||||||||||||||||||
NYSE Group Handled Volume 2 | 412 | 431 | -4.4% | 8,238 | 9,049 | -9.0% | 415 | -9.0% | 42,315 | -10.7% | ||||||||||
NYSE Group Matched Volume 3 | 337 | 360 | -6.5% | 6,734 | 7,564 | -11.0% | 343 | -9.6% | 34,955 | -11.3% | ||||||||||
Total Nasdaq Listed Consolidated Volume | 2,418 | 2,067 | 17.0% | 48,351 | 43,407 | 11.4% | 2,293 | 0.9% | 233,881 | -1.0% | ||||||||||
NYSE Group Share of Total Consolidated Volume | ||||||||||||||||||||
Handled Volume 2 | 17.0% | 20.8% | -3.8% | 17.0% | 20.8% | -3.8% | 18.1% | -2.0% | 18.1% | -2.0% | ||||||||||
Matched Volume 3 | 13.9% | 17.4% | -3.5% | 13.9% | 17.4% | -3.5% | 14.9% | -1.8% | 14.9% | -1.8% | ||||||||||
Exchange-Traded Funds 1,4 | ||||||||||||||||||||
NYSE Group Handled Volume 2 | 627 | 296 | 111.7% | 12,536 | 6,217 | 101.7% | 671 | 74.9% | 68,458 | 71.5% | ||||||||||
NYSE Group Matched Volume 3 | 548 | 257 | 113.0% | 10,964 | 5,406 | 102.8% | 590 | 76.5% | 60,137 | 73.1% | ||||||||||
Total ETF Consolidated Volume | 2,435 | 901 | 170.2% | 48,703 | 18,927 | 157.3% | 2,439 | 120.8% | 248,794 | 116.5% | ||||||||||
NYSE Group Share of Total Consolidated Volume | ||||||||||||||||||||
Handled Volume 2 | 25.7% | 32.8% | -7.1% | 25.7% | 32.8% | -7.1% | 27.5% | -7.2% | 27.5% | -7.2% | ||||||||||
Matched Volume 3 | 22.5% | 28.6% | -6.1% | 22.5% | 28.6% | -6.1% | 24.2% | -6.0% | 24.2% | -6.0% |
NYSE Euronext |
||||||||||||||||||||
Monthly Volume Summary - Derivatives Products |
||||||||||||||||||||
Average Daily Volume | Total Volume | Average Daily Volume | Total Volume | |||||||||||||||||
(Unaudited; contracts in thousands) | May-09 | May-08 | % Chg | May-09 | May-08 | % Chg | YTD 2009 |
% Chg vs. YTD 2008 |
YTD 2009 |
% Chg vs. YTD 2008 |
||||||||||
Number of Trading Days - European Markets | 20 | 21 | 20 | 21 | 103 | 103 | ||||||||||||||
Number of Trading Days - U.S. Markets | 20 | 21 | 20 | 21 | 102 | 102 | ||||||||||||||
European Derivatives Products | 5,584 | 4,348 | 28.4% | 111,670 | 91,316 | 22.3% | 4,266 | -5.0% | 439,388 | -6.8% | ||||||||||
of which Bclear | 2,373 | 1,347 | 76.2% | 47,451 | 28,277 | 67.8% | 1,189 | 52.4% | 122,496 | 49.5% | ||||||||||
Total Interest Rate Products | 2,171 | 2,007 | 8.2% | 43,421 | 42,145 | 3.0% | 2,002 | -21.6% | 206,188 | -23.1% | ||||||||||
Short Term Interest Rate Products | 2,047 | 1,888 | 8.4% | 40,931 | 39,643 | 3.2% | 1,900 | -22.3% | 195,727 | -23.7% | ||||||||||
Medium and Long Term Interest Rate Products 5 | 124 | 119 | 4.5% | 2,489 | 2,502 | -0.5% | 102 | -7.7% | 10,462 | -9.5% | ||||||||||
Total Equity Products 6 | 3,369 | 2,301 | 46.4% | 67,382 | 48,316 | 39.5% | 2,217 | 18.1% | 228,399 | 15.9% | ||||||||||
Individual Equity Products | 2,800 | 1,814 | 54.4% | 56,007 | 38,091 | 47.0% | 1,583 | 27.4% | 163,093 | 25.0% | ||||||||||
Equity Index Products | 569 | 487 | 16.8% | 11,375 | 10,225 | 11.2% | 634 | 0.0% | 65,306 | -1.9% | ||||||||||
of which Bclear | 2,373 | 1,347 | 76.2% | 47,451 | 28,277 | 67.8% | 1,189 | 52.4% | 122,496 | 49.5% | ||||||||||
Individual Equity Products | 2,266 | 1,262 | 79.6% | 45,330 | 26,498 | 71.1% | 1,054 | 54.1% | 108,602 | 51.2% | ||||||||||
Equity Index Products | 106 | 85 | 25.2% | 2,121 | 1,779 | 19.2% | 135 | 40.6% | 13,894 | 37.9% | ||||||||||
Commodity Products | 43 | 41 | 6.6% | 868 | 855 | 1.5% | 47 | -18.5% | 4,801 | -20.1% | ||||||||||
of which Bclear | ||||||||||||||||||||
U.S. Derivatives Products | ||||||||||||||||||||
U.S. Derivatives Products - Equity Options 7 | ||||||||||||||||||||
NYSE Group Options Contracts | 2,532 | 1,460 | 73.4% | 50,649 | 30,667 | 65.2% | 2,369 | 36.4% | 241,639 | 33.8% | ||||||||||
Total Consolidated Options Contracts | 14,805 | 11,757 | 25.9% | 296,098 | 246,900 | 19.9% | 13,738 | 8.2% | 1,401,309 | 6.1% | ||||||||||
NYSE Group Share of Total | 17.1% | 12.4% | 17.1% | 12.4% | 17.2% | 3.5% | 17.2% | 3.5% | ||||||||||||
NYSE Liffe U.S. | ||||||||||||||||||||
Precious Metals Futures Volume | 14.7 | - | 293.2 | - | 18.1 | - | 1,848.3 | - |
1 | Includes all volume executed in NYSE Group crossing sessions. | |
2 | Represents the total number of shares of equity securities and ETFs internally matched on the NYSE Group's exchanges or routed to and executed at an external market center. NYSE Arca routing includes odd-lots. | |
3 | Represents the total number of shares of equity securities and ETFs executed on the NYSE Group's exchanges. | |
4 | Data included in previously identified categories. | |
5 | Data includes currency products. | |
6 |
Includes all trading activities for Bclear, Euronext.liffe's clearing service for wholesale equity derivatives. | |
7 | Includes trading in U.S. equity options contracts, not equity-index options. | |
Source: NYSE Euronext, Options Clearing Corporation and Consolidated Tape as reported for equity securities. | ||
All trading activity is single-counted, except European cash trading which is double counted to include both buys and sells. | ||
US Equities data has been updated for Amex integration for October 2008 forward. |
Source: